butyric acid has been researched along with alpha-synuclein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bonn, S; Fischer, A; Gerhardt, E; Hennion, M; Kerimoglu, C; Outeiro, TF; Paiva, I; Pavlou, MA; Pinho, R; Rajput, A; Rego, AC; Schütz, AL; Szego, ÉM; Wales, P | 1 |
| Cui, C; Jia, XB; Qiao, CM; Shen, YQ; Shi, Y; Sun, MF; Zhang, BP; Zhao, LP; Zhou, ZL | 1 |
| Dubey, SK; K C, S; Kakoty, V; Taliyan, R; Yang, CH | 1 |
3 other study(ies) available for butyric acid and alpha-synuclein
| Article | Year |
|---|---|
Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage.
Topics: alpha-Synuclein; Butyric Acid; Cell Culture Techniques; DNA Damage; Dopaminergic Neurons; Gene Expression; Gene Expression Regulation; Humans; Parkinson Disease | 2017 |
Sodium butyrate causes α-synuclein degradation by an Atg5-dependent and PI3K/Akt/mTOR-related autophagy pathway.
Topics: alpha-Synuclein; Animals; Apoptosis; Autophagy; Autophagy-Related Protein 5; Butyric Acid; Cell Line; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
Neuroprotective Effects of Trehalose and Sodium Butyrate on Preformed Fibrillar Form of α-Synuclein-Induced Rat Model of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Butyric Acid; Disease Models, Animal; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Wistar; Trehalose | 2021 |